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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2014, TaiwanBackground: The parameters of oxidative stress [advanced oxidation protein products (AOPPs),
malondialdehyde (MDA), and S100B] and the effect of intensive phototherapy (PT) on these pa-
rameters have not been studied extensively in newborns with significant hyperbilirubinemia
(SH). We aimed to measure the levels of MDA, S100B, and AOPPs in newborns with SH, and
to compare newborns with healthy control newborns without hyperbilirubinemia on the basis
of these parameters of oxidative stress. In addition, we investigated the effect of intensive PT
on these parameters during the treatment of SH and report our findings for the first time in the
literature.
Methods: The study was performed in newborns (nZ 62) who underwent intensive PT because
of SH. Newborns without jaundice constituted the control group (n Z 30). Both groups were
compared with respect to demographic characteristics and biochemical (laboratory) parame-
ters including MDA, AOPPs, and S100B. MDA, AOPPs, and S100B were also compared before and
after intensive PT in the PT group. In the study group, a correlation analysis of demographic
characteristics; MDA, AOPP, and S100B values; and changes occurring in MDA, AOPPs, and
S100B values due to the effect of intensive PT was performed.eonatology, Department of Pediatrics, Erciyes University Faculty of Medicine, Talas Yolu, Melikgazi,
oo.com.tr (D. Sarici).
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96 D. Sarici et alResults: Serum total bilirubin, S100B, and MDA levels in the PT group before performing PT
were significantly higher than those in the control group. In newborns receiving PT serum total
bilirubin, MDA and AOPP levels decreased significantly after intensive PT. In correlation anal-
ysis, a statistically significant negative correlation was found only between the amount of bili-
rubin decrease with PT and AOPP levels after PT in the study group.
Conclusion: Whether the significant decrease in MDA levels, which was higher prior to PT, is
due to the decrease in serum bilirubin levels or due to the effect of intensive PT itself remains
to be determined in further studies. The decrease in AOPP levels after PT implies that inten-
sive PT has protective effects on oxidative stress.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
In neonatology, free radicals and their products, lipid and
protein peroxides, have been thought to be responsible for
the pathogenesis of many conditions such as retinopathy of
prematurity, bronchopulmonary dysplasia, intracranial
hemorrhage, periventricular leucomalacia, sepsis, necro-
tizing enterocolitis, and hypoxic ischemic encephalopathy.1
Bilirubin, at physiologic concentrations, protects neonatal
red blood cells against oxidative stress. However, increased
bilirubin concentrations are associated with significant
cytotoxicity,2 and significant hyperbilirubinemia (SH) may
cause an increase in free radicals and their products.2e4 On
the other hand, phototherapy (PT) itself, which is the most
commonly used treatment modality in SH, may also result
in the release of reactive nitrogen and oxygen species, and
photolysis products are cytotoxic and associated with the
production of free oxygen radicals.5 Ostrea et al6 reported
that the exposure of red cell suspension to PT light in the
presence of a sensitizer (bilirubin) resulted in oxidative
injury to the red cell membrane. Recently, in vitro fluo-
rescent light has been shown to cause a decrease in red
blood cell ATPase activity and an increase in lipid peroxi-
dation, and it has been hypothesized that specific areas of
the membrane, mainly the lipid/protein interface, are
differently affected.7 Various studies investigated the
relationship between PT and/or SH and malondialdehyde
(MDA) levels with conflicting results.3,4,8e15
Advanced oxidation protein products (AOPPs) are
formed during oxidative stress,1 and they are defined as
novel parameters of oxidative stress.16 There is a limited
number of studies about AOPPs during the neonatal period,
most of which have been conducted to investigate various
free radical-mediated diseases.1,17,18 However, to our
knowledge, no studies have investigated the relationship
between AOPPs and neonatal hyperbilirubinemia and/or
PT.
S100B protein levels in cerebrospinal fluid, plasma, or
serum have been used increasingly as biomarkers to eval-
uate the presence and severity of intraventricular hemor-
rhage, hypoxic ischemic encephalopathy, and brain
damage.19e21 Levels of S100B protein in neonatal SH were
investigated in only one study,22 and to our knowledge, the
effect of PT has not yet been determined.
Thus, we aimed to measure the levels of MDA, S100B,
and AOPPs in newborns with SH, and to compare thesenewborns with healthy control newborns without hyper-
bilirubinemia on the basis of these parameters of oxidative
stress. In addition, we investigated the effect of intensive
PT on these parameters during the treatment of SH for the
first time in the literature.2. Patients and methods
This study was performed on term and near-term (35
weeks) newborns who underwent intensive PT because of
SH between February 2011 and April 2013. A diagnosis of SH
was made if the serum total bilirubin levels of the newborns
were above the levels on age (hour)-specific bilirubin
curves determined on the basis of risk status and gesta-
tional age of the newborns.23,24 All infants were exposed
(completely unclothed, with their eyes and genitals
covered) to continuous PT that was interrupted only for
feeding, cleaning, and blood sampling. The infants’ weight
and temperature were closely monitored during PT.
Sex, type of delivery, weight, length, and head circum-
ference at birth, gestational age, age on admission, and
maternal age of the newborns were recorded. Infants with
any congenital malformation, prematurity (<35 weeks’
gestation) or postmaturity, maternal diabetes, birth
asphyxia, sepsis, or hemolytic-type hyperbilirubinemia due
to blood group (Rh or ABO) incompatibility were excluded
from the study. The study group comprised 62 newborns.
Intensive PT was chosen as the PT of choice in the
treatment of SH, according to the guidelines of the
American Academy of Pediatrics.23 For PT, an intensive PT
unit consisting of high-intensity gallium nitride light-
emitting diodes (light spectrum Z 450e470 nm and
irradiance  35 mW/cm2/nm; Bilicrystal IV. 2; Medestime
S.A. Charleroi, Belgium) was used. The system was placed
over the infants, at a distance of 40 cm. The irradiance
was maintained above 35 mW/cm2/nm during PT and
measured weekly. PT was stopped if serum bilirubin levels
fell at least 5 mg/dL below the limits defined necessary for
starting PT.
A control group (n Z 30) was constituted by the new-
borns who had no jaundice, and were about to be dis-
charged or came to the first control visit after hospital
discharge. Blood samples from these cases were obtained
during venipuncture performed for metabolic screening or
various other reasons (such as control of thyroid function
Table 1 Comparison of the demographic characteristics
of the study groups.
Control group
(n Z 30)
Phototherapy
group
(n Z 62)
p
Sex (male/female) 16/14 45/17 0.056
Type of delivery
(vaginal/cesarean)
18/12 37/25 0.580
Birth weight (g) 3246  287 3233  396 0.873
Length (cm) 49.99  0.7 49.79  1.96 0.480
Head
circumference (cm)
34.81  0.57 34.7  1.29 0.658
Gestational age (wk) 38.93  0.98 38.58  1.09 0.106
Age on admission (d) 5.23  2.06 5.27  2.15 0.933
Maternal age (y) 27.7  5.16 29.19  6.74 0.245
Figure 1 Comparison of the S100B levels in the control and
phototherapy (before and after phototherapy) groups.
MDA, S100B, AOPP in hyperbilirubinemia 97tests and evaluation of hyperbilirubinemia). The study was
approved by the ethics committee of the hospital, and
written informed parental consent was obtained.
Blood samples of all cases were used to study the
following parameters prior to PT (only once for the control
cases irrespective of PT): blood group, Rh type, direct
Coombs’ test results, complete blood count, findings of
liver function tests, serum total bilirubin, direct bilirubin,
MDA, AOPPs, and S100B. Serum total bilirubin, MDA, AOPPs,
and S100B were studied 24 hours after PT in the study (PT)
group. Blood samples obtained for MDA, AOPPs, and S100B
were stored at 70C after centrifugation until analysis of
all samples.
MDA levels in plasma were measured by the spectro-
photometric method,25 and the results were expressed as
micromoles per liter (mmol MDA/L).
Determination of AOPPs was based on a spectrophoto-
metric assay, according to Witko-Sarsat et al.16 AOPP levels
were expressed in terms of micromoles of chloramine-T
equivalents per liter of plasma (mmol/L).
S100B protein concentrations were analyzed using a
commercially available enzyme-linked immunosorbent
assay kit (BioVendor Laboratory Medicine, A.S., Modrice,
Czech Republic) according to the manufacturer’s protocol.
Results were expressed as pg/mL. Control and PT groups
were compared with respect to demographic characteris-
tics and biochemical (laboratory) parameters including
MDA, AOPPs, and S100B. MDA, AOPPs, and S100B were also
compared before and after PT in the PT group. In the study
group, a correlation analysis of demographic characteris-
tics; MDA, AOPP, and S100B values; and changes occurring
in MDA, AOPPs, and S100B values due to the effect of PT
was performed.
For statistical analysis, PASW Statistics 18.0 was used.
One-sample KolmogoroveSmirnov test was used to deter-
mine the distribution between groups. Independent sample
t test was used to compare the PT and control groups.
Paired sample t test was used to compare between the
parameters before and after PT in the PT group. Pearson
correlation analysis was performed to determine the cor-
relation between demographic characteristics and
biochemical (before and after PT) parameters. A value of
p  0.05 was accepted as statistically significant.Figure 2 Comparison of the MDA levels in the control and
phototherapy (before and after phototherapy) groups.
MDA Z malondialdehyde.3. Results
Demographic characteristics and their statistical compari-
son in the study and control groups are given in Table 1.
Sixty out of 62 newborns and 28 out of 30 newborns were
being exclusively breast-fed in the study and control
groups, respectively. There were no statistically significant
differences between the study groups regarding the de-
mographic characteristics. No newborns had glucose-6-
phosphate dehydrogenase deficiency or required exchange
transfusion as a further treatment modality in the study
group.
Serum total bilirubin (8.1  1.71 mg/dL vs.
20.58  2.96 mg/dL; p  0.001), S100B (87.3  32.63 pg/mL
vs. 124.97  123.05 pg/mL; p Z 0.032), and MDA levels
(5.55  0.6 nmol/mL vs. 7.72  0.75 nmol/mL; p  0.001)
prior to PT were statistically significantly higher in the PT
Figure 3 Comparison of the AOPP levels in the control and
phototherapy (before and after phototherapy) groups.
AOPP Z advanced oxidation protein product.
Figure 4 Correlation between the amount of bilirubin
decrease with phototherapy and AOPP levels after photo-
therapy. AOPP Z advanced oxidation protein product.
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AOPP levels (13.42  4.04 mmol/L vs. 13.19  3.77 mmol/L;
p Z 0.787) did not differ significantly between the two
groups (Figure 3).
In newborns receiving PT serum total bilirubin, MDA and
AOPP levels decreased significantly after PT (Table 2,
Figures 2 and 3), whereas S100B levels did not differ
significantly due to the effect of PT in the PT group (Table 2
and Figure 1).
In correlation analysis of all the demographic and
biochemical parameters, a statistically significant negative
correlation was observed only between the amount of
bilirubin decrease with PT and AOPP levels after PT in the
study group, indicating that bilirubin decrease with PT was
more prominent in cases with a more significant AOPP
decrease [r Z 0.366, t Z 0.001 (Figure 4)].
4. Discussion
In this study, S100B levels were measured to investigate
whether SH itself or intensive PT might cause a brain injury,
as increased S100B levels correlate with a greater degree of
brain damage. In the only other study with this aim, Oku-
mus et al22 evaluated 92 newborns with hyperbilirubinemia,
and observed that serum Tau and S100B proteins began to
increase when total serum bilirubin levels exceeded
19.1 mg/dL, and minor neurologic dysfunction, electroen-
cephalogram abnormalities, and auditory neuropathy star-
ted developing at total serum bilirubin levels of 22 mg/dL,Table 2 Comparison of the biochemical (laboratory) charact
(n Z 62).
Befo
Serum total bilirubin level (mg/dL) 20.5
S100B level (pg/mL) 124.9
Malondialdehyde level (nmol/mL) 7.7
Advanced oxidation protein product level (mmol/L) 13.124 mg/dL, and 25 mg/dL, respectively. They concluded that
serum levels of Tau and S100B proteins were strongly
correlated with early-phase bilirubin encephalopathy. In
the present study, S100B levels were significantly higher in
newborns with SH when compared to those without
hyperbilirubinemia, confirming the finding of the study of
Okumus et al.22 However, S100B levels did not demonstrate
a significant decrease after intensive PT, and the normali-
zation period of S100B levels in newborns with SH should be
followed with further longitudinal studies.
Increasing appreciation of the causative role of oxidative
injury and lipid peroxidation in the development of many
severe diseases of the newborn has lent tremendous
importance to lipid peroxidation and its possible causes.5
MDA is one of the most frequently used indicators of lipid
peroxidation. Plasma MDA concentrations in neonates with
SH were significantly higher than those in healthy in-
fants.3,4,8,10,11 Davutoglu et al3 and Yigit et al4 also re-
ported a significant correlation between MDA and bilirubin
levels. In contrast to these reports, only Kumar et al9 found
that jaundiced newborns had significantly lower MDA
levels. In our study, MDA levels were significantly higher in
newborns with SH requiring intensive PT in comparison to
control cases without hyperbilirubinemia, confirming the
finding reported by most of the related studies.3,4,8,10,11
There is a limited number of studies with controversial
results comparing MDA levels before and after PT. Ozture
et al10 and Aycicek and Erel13 reported that MDA concen-
trations decreased significantly with PT. Akisu et al12 re-
ported that MDA levels were not significantly different
before and after PT in 20 full-term infants. However, Erdemeristics before and after phototherapy in the study group
re phototherapy After phototherapy p
8  2.96 12.49  2.67 <0.001
7  123.05 127.28  94.92 0.91
2  0.75 7.52  0.79 0.04
9  3.77 11.51  3.77 <0.001
MDA, S100B, AOPP in hyperbilirubinemia 99et al14 and Dahiya et al15 showed that MDA levels were
higher after PT than before PT. In our study, MDA levels
decreased significantly after intensive PT, in accordance
with the results of the first two of these studies.
An imbalance between oxidant and antioxidant defense
systems results in excessive reactive oxygen species genera-
tion and oxidative stress, which is associated with oxidative
modification of proteins, lipids, and DNA, and leads to cell
transformation or cell death by apoptotic or necrotic mech-
anisms.26 AOPP is a novel marker of oxidant-mediated protein
damage.17 Recently, increased levels of AOPPs have been
found in premature patients with free radical-related dis-
eases,1 necrotizing enterocolitis (NEC),20 and hypoxia.22 To
our knowledge, there has been no study either about the
status of AOPPs in SHor about the effect of PT, and our study is
the first to investigate the levels of AOPPs in newbornswith SH
requiring PT, as well as the effect of intensive PTon the levels
of AOPPs. In comparison to healthy control newborns without
SH, we detected no significant difference in AOPP levels in
newborns with SH. However, with intensive PT, AOPP levels
decreased significantly, and the decrease in AOPP levels was
more prominent in cases with a more prominent bilirubin
decrease (correlation analysis).
The present study has two limitations. The first is that
studying jaundiced newborns with critically higher serum
bilirubin levels (i.e., >25e30 mg/dL) might have given
different and more significant results. The second is that
following the parameters of oxidative stress in a more
longitudinal manner would have revealed the normalization
period of these parameters.
In the present study, S100B levels were significantly
higher in newborns with SH than in those without hyper-
bilirubinemia, and these levels did not demonstrate a sig-
nificant decrease after intensive PT. However, the
normalization period of S100B levels in newborns with SH
should be followed with further longitudinal studies.
Accordingly, MDA levels, which were also higher before PT,
decreased after intensive PT; however, whether this
decrease is due to the decrease in serum bilirubin levels or
due to the effect of intensive PT itself remains to be
determined in further studies. Unlike S100B and MDA, AOPP
levels were not significantly different in newborns with SH.
However, the significant decrease in AOPP levels after PT
confirms the antioxidant efficacy of intensive PT.
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